Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of topical AMP-380-02 subcutaneous injection for fat localization and to determine optimal doses in obese patients with abdominal and lateral fats Phase 2b clinical tria

StatusFinished
Effective start/end date15/06/1331/12/14